Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 551 - 600 out of 9,655

Document Document Title
WO/2008/147480A2
Compounds having the formula (I) wherein the symbols have the meaning described in the specification are hydroxamic acid derivatives of 3 -phenyl-propionic acid and capable of inhibiting the lethal effects of infection by anthrax bacteri...  
WO/2008/145865A2
The present invention relates to mutated hyperthermophilic phosphotriesterases (PTEs) which have lactonase activity, and to the uses thereof as biopurifiers in the context of the decontamination of surfaces of materials, of the skin or o...  
WO/2008/147480A3
Compounds having the formula (I) wherein the symbols have the meaning described in the specification are hydroxamic acid derivatives of 3 -phenyl-propionic acid and capable of inhibiting the lethal effects of infection by anthrax bacteri...  
WO/2008/143182A1
Disclosed is a composition comprising a licorice-derived polyphenol and an active ingredient other than the licorice-derived polyphenol (an antioxidant component, a polyphenol other than the licorice-derived polyphenol, or a component in...  
WO/2008/138358A1
Electrolyzed water with pH = 9.5 +/- 1.5 & ORP = -250 to -400 mv used for drinking for maintaining human health since it has antioxidant effects thus prevents a lot of diseases. Also it can be used for diet as it neutralizes excess acidi...  
WO/2008/135984A1
The present invention relates to S-allylmercapto-N-acetylcysteine (ASSNAC) and its pharmaceutically acceptable salts and solvates, which are useful for up-regulation of cellular glutathione levels and expression of phase II detoxifying e...  
WO/2008/134630A1
Methods are disclosed of treating conditions associated with iron and calcium overload comprising administering an effective amount of dexrazoxane or a non- dexrazoxane compound of formula (IA), (IB), or (IC) or a pharmaceutically accept...  
WO/2008/129980A1
Disclosed is a particulate composition which contains reduced coenzyme Q10 and which has both high stability in oxygen and high bioabsorbability in the field of a food, a food with a nutrient function, a food for specified health uses, a...  
WO/2008/129720A1
It is intended to provide a moisturizing agent, an antiaging agent, a whitening agent, an antioxidant, a slimming agent, a treatment agent and an alginase activity promoter which contain an extract of a plant belonging to the genus Cynan...  
WO/2008/130395A3
A pharmaceutical composition comprising a non-toxic effective amount of an actinide decorporation agent and a pharmaceutically acceptable carrier therefore, the actinide decorporation agent comprising a hexacoordinate desferrithiocin ana...  
WO/2008/130395A2
A pharmaceutical composition comprising a non-toxic effective amount of an actinide decorporation agent and a pharmaceutically acceptable carrier therefore, the actinide decorporation agent comprising a hexacoordinate desferrithiocin ana...  
WO/2008/126752A1
A skin-lightening agent containing a novel skin-lightening ingredient as an active ingredient. The active ingredient comprises equol and/or an equol glycoside formed by bonding one or more glycosyl groups to one or more of the hydroxy gr...  
WO/2008/125724A1
The present invention relates to monitoring ofoxidative metabolism and is, particularly, directed to a method for the estimation of lipid peroxide load or the consequent inflamma- torystate of a subject by measuring the concentration of ...  
WO/2008/123093A1
Disclosed is an agent for prevention or treatment of iron overload, which contains 22β-methoxyolean-12-ene-3β,24(4β)-diol or a pharmacologically acceptable salt thereof.  
WO/2008/119556A3
The present invention relates to a method for producing an extract which is capable of inducing an antioxidant stress response comprising the step of treating an extract from organic material with UV light, said extract being derived fro...  
WO/2008/121568A2
A mounting device (10) may comprise a base (20) having first and second sides and having a cavity (30) in the first side thereof; a pin (50) in the cavity (30) and extending from the base (20) to define an axial direction; a plate (40) d...  
WO/2008/120778A1
It is intended to provide a composition for promoting the formation of a ketone compound which contains a water-soluble β-hydroxy short to medium chain fatty acid polymer. This composition for promoting the formation of a ketone compoun...  
WO/2008/120708A1
It is intended to provide a means for enhancing the engraftment rate or proliferation rate in a transplanted tissue in vivo by establishing a tissue transplantation method wherein a single donor is sufficient for a single recipient with ...  
WO/2008/119852A1
Extract of Couroupita guianenis leaves, method for obtaining same and cosmetic use thereof as an antioxidant/antiradical/UV (ultraviolet) filter. Extracts obtained from dry, ground and sieved leaves, extraction with water and/or alcohols...  
WO/2008/116301A1
The present invention relates to novel derivatives of deferiprone. In particular, the present invention relates to fluorinated derivatives of deferiprone or pharmaceutically acceptable salts thereof, pharmaceutical compositions comprisin...  
WO/2008/117815A1
An inhibitor for cell death caused by endoplasmic reticulum stress or oxidation stress which contains, as the active ingredient, a carbazole derivative represented by the following general formula (I) or a pharmaceutically acceptable sal...  
WO/2008/117481A1
It is intended to provide a moisturizer, an antiaging agent, an antiobesity agent, an antioxidant agent and an antiinflammatory agent which contain an active ingredient originating in a natural material and are applicable to a skin prepa...  
WO/2008/114660A1
[PROBLEMS] To provide: a composition derived from a natural plant and having a antioxidant activity, specifically a composition particularly for oral applications which is derived from a natural plant having a characteristic bitter or as...  
WO/2008/113134A1
The present invention relates to a method for transplanting a kidney from a donor to a recipient. In a preferred embodiment, the method involves administering an iron chelator to the donor prior to harvesting the kidney and/or administer...  
WO/2008/115433A1
A relatively non-toxic desazadesferrithiocin analog having the formula (I): wherein: R1, R2, R4 and R5 may be the same or different and may be H, straight or branched chain alkyl having up to 14 carbon atoms, e.g., methyl, ethyl, propyl ...  
WO/2008/111244A1
An external preparation for the skin, a cell activator, a collagen production promoter, a hyaluronic acid production promoter, an antioxidant agent, a melanin formation inhibitor, a fat accumulation inhibitor, an adiponectin production p...  
WO/2008/106715A1
The invention provides oxazinyl isoflavonoid compounds and compositions containing same, methods for their preparation and their use as therapeutic agents particularly as cardioprotective, anti-inflammatory, anti-oxidant and chemotherape...  
WO/2008/105325A1
Disclosed is a beverage which can exert various useful functions of arginine, is easy to drink and has excellent stability. Specifically disclosed is a beverage containing 0.5 to 10% by weight of citrulline, 0.1 to 40% by weight of a sug...  
WO/2008/105392A1
Disclosed is a substance for inhibiting cell death, which is effective as a prophylactic or therapeutic agent for the progress of a condition of a disease whose of progress or exacerbation is associated with cell death. Specifically disc...  
WO/2008/102584A1
Disclosed is a novel compound which can be used as a pharmaceutical agent, a cosmetic, a health food, a food additive or the like. Specifically disclosed is a flavanol compound shown by the formula (1). (1)  
WO/2008/102467A1
Disclosed is an external preparation for the skin, which is characterized by comprising a blue-green alga belonging to the family Chroococcus or an extract thereof. Also disclosed is a functional oral composition characterized by compris...  
WO/2008/101195A2
The present invention is directed to compounds, compositions, and methods for halting or reversing the effects of chemoresistance in neoplastic diseases. In particular the use of hydroxylamines is described.  
WO/2008/099924A1
Disclosed are: a novel strain of an alga belonging to the genus Chlorella, which has a high proliferation ability in culture in the darkness, and has a high chlorophyll content and a high active oxygen scavenging effect; and a compositio...  
WO/2008/101195A4
The present invention is directed to compounds, compositions, and methods for halting or reversing the effects of chemoresistance in neoplastic diseases. In particular the use of hydroxylamines is described.  
WO/2008/099144A2
The invention relates to the use of TGF-beta stimulating agents, and in particular members of the triphenylethylene class of pharmaceutical agents, for the prevention, prophylaxis, treatment or amelioration of symptoms of cardiovascular ...  
WO/2008/101195A3
The present invention is directed to compounds, compositions, and methods for halting or reversing the effects of chemoresistance in neoplastic diseases. In particular the use of hydroxylamines is described.  
WO/2008/099804A1
Disclosed is a therapeutic agent for diabetic cataract which has effective delay activity on the progress of diabetic cataract. The therapeutic agent comprises an antioxidant agent capable of preventing the impaired oxidation in the reti...  
WO/2008/095366A1
A porphyrin derivative and its pharmaceutical acceptable salt and its preparation method. The said porphyrin derivative is M-5,10,15,20-tetra[3-ethylene polyol monomethyl ether-substituted -phenyl]porphyrin, in which M is one of Fe, Mn, ...  
WO/2008/094061A1
The invention relates to biology and medicine, in particular, it can be used in medicine for preparing a pharmacological composition used for accelerated healing of wounds and the damages by means of addressed (directed) delivery of biol...  
WO/2008/095093A2
This invention provides a method of improving glutathione (GSH) concentrations, both intra and extra-cellularly, in animals, thereby improving the cellular function of the immune and other bodily organ functions. The invention is directe...  
WO/2008/094062A1
The invention relates to pharmacology, medicine and oncology, in particular, to a class of chemical compounds, the structure of which corresponds to formula (I) and which can be used in pharmaceutical compositions for preventing and trea...  
WO/2008/093302A3
The present invention is directed to a method for decreasing inflammation and oxidative stress in a mammal comprising; administration to a mammal a composition comprising a glucose antimetabolite; and wherein said composition comprises a...  
WO/2008/093302A2
The present invention is directed to a method for decreasing inflammation and oxidative stress in a mammal comprising; administration to a mammal a composition comprising a glucose antimetabolite; and wherein said composition comprises a...  
WO/2008/095093A3
This invention provides a method of improving glutathione (GSH) concentrations, both intra and extra-cellularly, in animals, thereby improving the cellular function of the immune and other bodily organ functions. The invention is directe...  
WO/2008/090749A1
Disclosed is an agent for the modification of an SH group or a cell-protecting agent, which can selectively react particularly with a highly reactive SH group in an intracellular environment where SH-containing proteins having various ty...  
WO/2008/088047A1
Disclosed is a method for producing a glycoside of a flavonoid, which comprises the step of reacting the flavonoid and a sugar donor with an enzymatic agent having a glycosylation activity and derived from a bacterium belonging to the ge...  
WO/2008/084828A1
Disclosed is a method for commercially and efficiently producing a coenzyme Q10 particle having high content and excellent powder flow characteristics by simple facilities and simple operations. Specifically disclosed is a method for pro...  
WO/2008/079993A3
The present invention provides methods of reducing the cytotoxic effects of nitric oxide and sulfides comprising coadministering nitric oxide with sulfide. In addition, the present invention provides novel pharmaceutical compositions com...  
WO/2008/079993A2
The present invention provides methods of reducing the cytotoxic effects of nitric oxide and sulfides comprising coadministering nitric oxide with sulfide. In addition, the present invention provides novel pharmaceutical compositions com...  
WO/2008/074091A1
The invention relates to radioprotectors of formula (I), processes for their preparation and their use in protecting biological materials from radiation damage. In diagnostic and therapeutic radiology, particularly in cancer radiotherapy...  

Matches 551 - 600 out of 9,655